FT-104
- Investigational
- 1-[3-[2-[Bis(1-methylethyl)amino]ethyl]-1H-indol-4-yl] pentanedioate
- 2756001-39-3 N
- 162510634
- Interactive image
- CC(C)N(CCC1=CNC2=C1C(=CC=C2)OC(=O)CCCC(=O)O)C(C)C
- InChI=1S/C21H30N2O4/c1-14(2)23(15(3)4)12-11-16-13-22-17-7-5-8-18(21(16)17)27-20(26)10-6-9-19(24)25/h5,7-8,13-15,22H,6,9-12H2,1-4H3,(H,24,25)
- Key:LSDOIAGGRBGDJJ-UHFFFAOYSA-N
FT-104 (also known as RE-104 and 4-glutaryloxy-N,N-diisopropyltryptamine) is a psychedelic tryptamine derivative which is a prodrug ester of the well known designer drug 4-HO-DiPT.[1] It is one of a number of related derivatives developed for potential medical applications, and is in human clinical trials as a possible treatment for postpartum depression and treatment-resistant depression.[2][3][4][5]
It is being developed by the pharmaceutical company Reunion Neuroscience.[6] As of 2024, FT-104 is entering Phase II clinical trials for post-partum depression.[7]
Pharmacology
FT-104 is a prodrug that is converted into the psychedelic tryptamine 4-HO-DiPT upon administration.[1][8] 4-OH-DiPT then acts as an agonist on the serotonin 2A receptor which leads to an antidepressant effect.[6]
See also
References
- ^ a b Bryson N, Alexander R, Asnis-Alibozek A, Ehlers MD (June 2024). "RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine". ACS Chemical Neuroscience. 15 (12): 2386–2395. doi:10.1021/acschemneuro.4c00058. PMC 11191588. PMID 38758589.
- ^ Hallifax J (11 August 2022). "An Inside Look into Field Trip's Next-Generation Psychedelic, FT-104".
- ^ WO 2022/000091, Bryson N, "Tryptamine prodrugs", published 6 January 2022, assigned to Field Trip Psychedelics Inc.
- ^ US 2022/0024956, Slassi A, Araujo J, "Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders.", published 27 January 2022, assigned to Mindset Pharma Inc.
- ^ WO 2022/246572, Slassi A, Araujo J, Higgin GH, Gabriele J, "Hallucinogen-Fatty Acid Combination", published 1 December 2022, assigned to Mindset Pharma Inc.
- ^ a b Braner S (May 8, 2024). "Reunion Neuroscience raises $103 million for a psychedelic to treat depression". Chemical & Engineering News.
- ^ Alexander R, Hocevar-Trnka J (June 26, 2024). "RE104: A Novel, Fast-Acting Psychedelic for Postpartum Depression". psychiatrictimes.com.
- ^ "Reunion Neuroscience Announces Publication of Results from Early Preclinical Studies Demonstrating the Potential of RE104 for Development in Depressive Disorders". GlobalNewswire. May 20, 2024 – via Yahoo!Finance.
- v
- t
- e
- 1-Methylpsilocin
- 2-HO-NMT
- 2-Me-DET
- 2-Methyl-5-HT
- 2,N,N-TMT
- 4,5-DHP-DMT
- 4-AcO-DALT
- 4-AcO-DET
- 4-AcO-DiPT
- 4-AcO-EPT
- 4-AcO-NMT
- 4-AcO-MALT
- 4-AcO-MET
- 4-AcO-DPT
- 4-AcO-MiPT
- 4-F-5-MeO-DMT
- 4-HO-5-MeO-DMT
- 4-HO-DALT
- 4-HO-DBT
- 4-HO-DET
- 4-HO-DiPT
- 4-HO-DPT
- 4-HO-DSBT
- 4-HO-EPT
- 4-HO-MALT
- 4-HO-MET
- 4-HO-McPT
- 4-HO-McPeT
- 4-HO-MiPT
- 4-HO-MPT
- 4-HO-MsBT
- 4-HO-NALT
- 4-HO-NMT
- 4-HO-PiPT
- 4-HO-pyr-T
- 4-MeO-DiPT
- 4-MeO-DMT
- 4-MeO-MiPT
- 4-PrO-DMT
- 4,5-MDO-DMT
- 4,5-MDO-DiPT
- 5-BT
- 5-Bromo-DMT
- 5-CT
- 5-Chloro-DMT
- 5-Ethoxy-DMT
- 5-Ethyl-DMT
- 5-Fluoro-DET
- 5-Fluoro-DMT
- 5-Fluoro-EPT
- 5-Fluoro-MET
- 5-HO-DiPT
- 5-HTP (oxitriptan)
- 5-MeO-2-TMT
- 5-MeO-34MPEMT
- 5-MeO-7,N,N-TMT
- 5-MeO-DALT
- 5-MeO-DBT
- 5-MeO-DET
- 5-MeO-DiPT
- 5-MeO-DMT
- 5-MeO-DPT
- 5-MeO-EiPT
- 5-MeO-EPT
- 5-MeO-MALT
- 5-MeO-MET
- 5-MeO-MiPT
- 5-MeO-NMT
- 5-MeO-pyr-T
- 5-MeO-NBpBrT
- 5-MeO-T-NBOMe
- 5-MeS-DMT
- 5-Methoxytryptamine (5-MT; mexamine)
- 5-Methyl-DMT
- 5-Methyltryptamine
- 5-MT-NB3OMe
- 5-(Nonyloxy)tryptamine
- 5,6-MeO-MiPT
- 5,6-MDO-DiPT
- 5,6-MDO-DMT
- 5,6-MDO-MiPT
- 5,6-DHT
- 5,7-DHT
- 6-Fluoro-DMT
- 7-Methyl-DMT
- Acetryptine (5-AT)
- Aeruginascin (4-PO-TMT)
- AGH-107
- AGH-192
- AH-494
- ALiPT
- Baeocystin (4-PO-NMT)
- Benzotript (4-chlorobenzoyl-L-tryptophan)
- Bufotenidine (5-HTQ)
- Bufotenin (5-HO-DMT)
- Convolutindole A
- CP-132,484
- DALT
- DBT
- Desformylflustrabromine
- DET
- DiPT
- DMT
- DPT
- E-6801
- E-6837
- EiPT
- EMDT
- EPT
- Ethocybin (4-PO-DET)
- FGIN-127
- FGIN-143
- FT-104
- HIOC
- Idalopirdine
- Indolylethylfentanyl
- Indorenate
- Iprocin (4-HO-DiPT)
- Lespedamine
- MET
- Methylbutyltryptamine
- Miprocin (4-HO-MiPT)
- MiPT
- MPT
- Milipertine
- MS-245
- MSBT
- N-Feruloylserotonin (moschamine)
- NET
- NMT
- Norbaeocystin (4-PO-T)
- NTBT
- O-4310
- Oxypertine
- PiPT
- Psilacetin (O-acetylpsilocin; 4-AcO-DMT)
- Psilocin (4-HO-DMT)
- Psilocybin (4-PO-DMT)
- Pyr-T
- RS134-49
- Serotonin (5-HT)
- Solypertine
- ST-1936
- Tryptamine
- Tryptophan
- Yuremamine
- Z2876442907
- 2-Iodomelatonin
- 2-Phenylmelatonin
- 5-Methoxyluzindole
- 6-Chloromelatonin
- 6-Fluoromelatonin
- 6-Hydroxymelatonin
- 6-Methoxymelatonin
- 6,7-Dichloro-2-methylmelatonin
- Luzindole
- Melatonin
- Normelatonin (N-acetylserotonin; NAS)
- N-Acetyltryptamine
- N-Butanoylmelatonin
- N-Propionylmelatonin
- Piromelatine
- TIK-301
- 2,α-DMT
- 4-HO-αMT
- 4-HO-MPMI (lucigenol)
- 4-Me-αET
- 4-Me-αMT
- 5-Chloro-αMT
- 5-Ethoxy-αMT
- 5-Fluoro-αET
- 5-Fluoro-αMT
- 5-iPrO-αMT
- 5-MeO-αET
- 5-MeO-αMT
- 5-MeO-MPMI
- 5-Methyl-αET
- 6-Fluoro-αMT
- 7-Chloro-αMT
- 7-Methyl-αET
- α-Methylserotonin (5-HO-αMT)
- α-Methyltryptophan (αMTP)
- α,N-DMT (N-methyl-αMT)
- α,N,N-TMT
- α,N,O-TMS
- αET (etryptamine)
- αMT
- AL-37350A (4,5-DHP-αMT)
- BNC-210
- BW-723C86
- CP-135807
- IPAP (α,N-DPT)
- MPMI
- Bay R 1531
- Ciclindole
- Cyclic 3-OHM
- Ergolines and lysergamides (e.g., LSD)
- Flucindole
- Harmala alkaloids and β-carbolines (e.g., 6-MeO-THH, 9-Me-BC, β-carboline (norharman), harmaline, harmalol, harmane, harmine, pinoline, tetrahydroharmine, tryptoline)
- Iboga alkaloids and related (e.g., DM-506 (ibogaminalog), ibogaine, ibogamine, noribogaine, tabernanthalog, tabernanthine)
- Metralindole
- NDTDI
- PHA-57378
- PNU-22394
- PNU-181731
- RU-28306
- Yohimbans (e.g., yohimbine, rauwolscine, spegatrine, corynanthine, ajmalicine, reserpine, deserpidine, rescinnamine)
- 2-Azapsilocin
- 4-Aza-5-MeO-DPT
- 5-Aza-4-MeO-DiPT
- 5-HIAL
- 5-MIAL
- 7-Aza-5-MeO-DiPT
- AAZ-A-154
- AL-34662
- AL-38022A
- BRL-54443
- CP-94253
- EMD-386088
- I-32
- IAL
- Latrepirdine
- LY-367265
- Pirlindole
- (R)-69 (3IQ)
- Ro60-0175
- Ro60-0213
- RU-24,969
- Sertindole
- SN-22
- Substituted benzofurans (e.g., 3-APB, 5-MeO-DiBF, BPAP, dimemebfe, mebfap)
- Tepirindole
- Tetrindole
- Triptans (e.g., avitriptan, LY-334370, naratriptan)
- VER-3323
- VU6067416
- YM-348